Latest Breaking News On - Bio announces positive phase - Page 1 : comparemela.com

FDA Grants Orphan Drug Designation to Felzartamab for Kidney Transplant Recipients

Previously, felzartamab received orphan drug designation and breakthrough therapy designation for the treatment of primary membranous nephropathy.

United statesUptal patelDrug administration for primary membranous nephropathyAmerican society of nephrology kidney weekOrphan drug designationHuman immunology biosciencesAmerican societyNephrology kidney weekBreakthrough therapy designationBio receivesDrug designationAntibody mediated rejectionKidney transplantBio announces positive phasePrimary membranousDrug administration

Investigational mAb Felzartamab Provides Promising Data for PMN

Positive phase 2 data from 2 studies on the investigational monoclonal antibody felzartamab designed to deplete CD38+ plasma cells, demonstrated reduced pathogenic antibody levels in primary membranous nephropathy.

Brad rovinTravis murdochDivision of nephrology at ohio state universityDrug administrationHuman immunology biosciencesOhio state universityBio announces positive phasePrimary membranous

Deadline Alert: Kessler Topaz Meltzer & Check, LLP Alerts Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Against Annovis Bio, Inc.

Deadline Alert: Kessler Topaz Meltzer & Check, LLP Alerts Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Against Annovis Bio, Inc.
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesJames maro jrJames maroAnnovis bioAlzheimer disease cooperative studyAnnovis bio incKessler topaz meltzerDeadline reminderClass periodDisease cooperative studyBio announces positive phasePatient cognition improvedTopaz meltzer

Deadline Alert: Kessler Topaz Meltzer & Check, LLP Alerts Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Against Annovis Bio, Inc.

Class Action Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Annovis Bio, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit

Class Action Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Annovis Bio, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.